Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05372614
Title Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Comprehensive Cancer Center RECRUITING Duarte California 91010 United States Details
City of Hope at Irvine Lennar RECRUITING Irvine California 92618 United States Details
City of Hope Antelope Valley RECRUITING Lancaster California 93534 United States Details
UC Irvine Health/Chao Family Comprehensive Cancer Center RECRUITING Orange California 92868 United States Details
University of California Davis Comprehensive Cancer Center SUSPENDED Sacramento California 95817 United States Details
City of Hope South Pasadena RECRUITING South Pasadena California 91030 United States Details
City of Hope Upland RECRUITING Upland California 91786 United States Details
Northwestern University RECRUITING Chicago Illinois 60611 United States Details
University of Kentucky/Markey Cancer Center RECRUITING Lexington Kentucky 40536 United States Details
Dana-Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
Washington University School of Medicine RECRUITING Saint Louis Missouri 63110 United States Details
University of Pittsburgh Cancer Institute (UPCI) RECRUITING Pittsburgh Pennsylvania 15232 United States Details
M D Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
University of Wisconsin Carbone Cancer Center RECRUITING Madison Wisconsin 53792 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field